KPL vs ZOTA: Stock Comparison

Kwality Pharmaceuticals Ltd vs Zota Health Care Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Zota Health Care Ltd is the larger company by market capitalisation. Kwality Pharmaceuticals Ltd shows a higher ROE, a higher ROCE and a higher net margin, while Zota Health Care Ltd shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kwality Pharmaceuticals Ltd and Zota Health Care Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KPL is more favourable on 6 of 13 scored metrics and ZOTA on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ZOTA is the larger company
₹4,432 Cr vs ₹2,692 Cr
P/E Ratio
ZOTA has a lower P/E
-59.88x vs 39.83x
P/B Ratio
ZOTA has a lower P/B
6.38x vs 8.09x
EPS
KPL has higher earnings per share
₹64.9 vs ₹-21.4
Dividend Yield
ZOTA has a higher dividend yield
0.08% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
67.8% vs 35.8%
Qtr Profit Growth
KPL has stronger quarterly profit growth
74.6% vs 31.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKPLZOTA
SectorHealthcare
IndustryPharmaceuticals

Price

MetricKPLZOTA
Live Price₹2,590.4₹1,274.9
Day Change-4.34%-0.64%
Volume26,34257,134
52-Week High₹2,890.3₹1,740
52-Week Low₹1,561₹1,026.2
Distance from 52W High-10.38%-26.73%

Valuation

MetricKPLZOTA
Market Cap₹2,692 Cr₹4,432 Cr
P/E Ratio39.83x-59.88x
P/B Ratio8.09x6.38x
EPS₹64.9₹-21.4
Book Value₹320₹200
Dividend Yield0%0.08%

Growth

MetricKPLZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth35.8%67.8%
Qtr Profit Growth74.6%31.1%

Profitability & Leverage

MetricKPLZOTA
ROE22.8%-15%
ROCE24.2%-8.47%
Net Margin13.39%-13.98%
Operating Margin23.5%3.44%
Debt to Equity0.39x0.39x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricKPLZOTA
Promoter Holding54.87% 0.04 pp49.38%
FII Holding2.79% 2.29 pp7.92% 0.29 pp
DII Holding0.36% 0.03 pp6.75% 0.35 pp
Public Holding41.98% 2.36 pp35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kwality Pharmaceuticals Ltd and Zota Health Care Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.